NMTC ▲ +3.6% - NeuroOne Medical Technologies Corporation $NMTC - NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement NeuroOne Medical Technologies rose 3.6% following news that it has secured a new distribution agreement in Southern California for its FDA-cleared OneRF® Trigeminal Nerve Ablation System, expanding the company's commercial reach for the neurosurgical device. The expanded distribution partnership signals progress in bringing the company's core product to a larger patient population in a major U.S. market. 17-SEP-2026 09:05 AM ET